13F HOLDINGS REPORT
Medicxi Ventures Management (Jersey) Ltd
Quarter ended Q3 2025 · Filed October 17, 2025 · Accession 0001193125-25-242131
Total Value
$744.4M
Positions
5
Other Managers
1
Confidential Omitted
No
Holdings (5)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | CENTESSA PHARMACEUTICALS PLC | CNTA | 19,963,157 | $484.1M | 65.03% |
| 2 | PHATHOM PHARMACEUTICALS INC | PHAT | 7,464,572 | $87.9M | 11.80% |
| 3 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 2,869,565 | $81.6M | 10.96% |
| 4 | RAPT THERAPEUTICS INC | 75382E109 | 2,794,000 | $72.1M | 9.68% |
| 5 | AURA BIOSCIENCES INC | AURA | 3,039,892 | $18.8M | 2.52% |